Patents by Inventor Mandana Namdar

Mandana Namdar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HDAC 6 inhibitor-based methods for treating cancer
    Patent number: 9539272
    Abstract: This invention provides methods for treating a subject afflicted with cancer, comprising concurrently administering (i) an HDAC 6-selective inhibitor and (ii) a suitable cytotoxic agent such as SAHA, doxorubicin or etoposide. This invention also provides methods for inducing the death of a transformed cell such as a cancer cell, comprising concurrently contacting the cell with (i) an HDAC 6-selective inhibitor and (ii) a suitable cytotoxic agent such as SAHA, doxorubicin or etoposide.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: January 10, 2017
    Assignee: SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
    Inventors: Paul A. Marks, Weisheng Xu, Mandana Namdar
  • HDAC 6 INHIBITOR-BASED METHODS FOR TREATING CANCER
    Publication number: 20120270818
    Abstract: This invention provides methods for treating a subject afflicted with cancer, comprising concurrently administering (i) an HDAC 6-selective inhibitor and (ii) a suitable cytotoxic agent such as SAHA, doxorubicin or etoposide. This invention also provides methods for inducing the death of a transformed cell such as a cancer cell, comprising concurrently contacting the cell with (i) an HDAC 6-selective inhibitor and (ii) a suitable cytotoxic agent such as SAHA, doxorubicin or etoposide.
    Type: Application
    Filed: July 2, 2010
    Publication date: October 25, 2012
    Inventors: Paul A. Marks, Weisheng Xu, Mandana Namdar